Nantkwest Inc CS (NK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NK | AZN | AMGN | GILD | BMY |
| Company | Nantkwest Inc CS | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Bristol-Myers Squibb Company |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NYSE |
| Open | 30.34 | 199.78 | 352.72 | 139.61 | 60.23 |
| High | 33.15 | 204.34 | 354.16 | 141.34 | 60.58 |
| Low | 29.74 | 199.23 | 345.87 | 138.64 | 59.10 |
| Latest | 32.49 | 203.47 | 348.05 | 139.67 | 59.60 |
| Change | +4.21 | +2.74 | -5.23 | -0.63 | -1.50 |
| % Change | +14.89% | +1.37% | -1.48% | -0.45% | -2.45% |
| Volume | 1,109,000 | 1,800,279 | 1,045,601 | 2,806,093 | 10,422,370 |
| 20-Day Average Volume | 1,620,320 | 1,817,464 | 2,636,206 | 6,028,674 | 13,433,186 |
| Previous Close | 28.28 | 200.73 | 353.28 | 140.30 | 61.10 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 31.51 | 191.38 | 358.31 | 141.23 | 59.31 |
| 20-Day Raw Stochastic | 41.94% | 92.98% | 8.41% | 33.70% | 51.69% |
| 20-Day Relative Strength | 58.89 | 59.55 | 43.18 | 47.03 | 51.26 |
| Weighted Alpha | +342.67 | +49.25 | +19.78 | +30.70 | +17.20 |
| Today's Opinion | 100% Buy | 88% Buy | 40% Buy | 40% Buy | 100% Buy |
| Previous Opinion | 80% Buy | 80% Buy | 40% Buy | 40% Buy | 100% Buy |
| Last Month's Opinion | 100% Buy | 88% Buy | 100% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +14.56% since 03/02/21 | +10.57% since 03/26/26 | -1.49% since 03/26/26 | +1.63% since 03/26/26 | +0.01% since 03/26/26 |
| Low | 23.15 on 03/05/21 | 187.95 on 03/27/26 | 345.87 on 04/02/26 | 133.89 on 03/30/26 | 58.37 on 03/27/26 |
| High | 33.15 on 03/09/21 | 204.32 on 04/02/26 | 357.00 on 04/01/26 | 141.49 on 04/01/26 | 62.22 on 04/01/26 |
| 1-Month | |||||
| %Chg | +15.79% since 02/09/21 | -0.47% since 03/02/26 | -9.80% since 03/02/26 | -7.28% since 03/02/26 | -4.66% since 03/02/26 |
| Low | 23.15 on 03/05/21 | 182.39 on 03/24/26 | 344.95 on 03/20/26 | 133.89 on 03/30/26 | 56.45 on 03/24/26 |
| High | 45.42 on 02/22/21 | 204.32 on 04/02/26 | 381.74 on 03/03/26 | 149.38 on 03/10/26 | 62.58 on 03/04/26 |
| 3-Month | |||||
| %Chg | +216.36% since 12/09/20 | +10.72% since 01/02/26 | +6.19% since 01/02/26 | +14.40% since 01/02/26 | +11.18% since 01/02/26 |
| Low | 10.00 on 12/10/20 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 52.06 on 01/05/26 |
| High | 45.42 on 02/22/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| 6-Month | |||||
| %Chg | +393.77% since 09/09/20 | +21.21% since 10/02/25 | +16.98% since 10/02/25 | +25.82% since 10/02/25 | +29.97% since 10/02/25 |
| Low | 6.51 on 09/11/20 | 160.96 on 11/04/25 | 288.00 on 10/31/25 | 109.66 on 10/03/25 | 42.52 on 10/29/25 |
| High | 45.42 on 02/22/21 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 62.89 on 03/02/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,552,620 | 311,313,728 | 190,441,936 | 174,143,456 | 126,036,304 |
| Shares Outstanding, K | 109,345 | 1,550,908 | 539,068 | 1,241,222 | 2,041,735 |
| Annual Sales | 110,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 48,194,000,000 |
| Annual Net Income | -92,380,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 7,054,000,000 |
| Last Quarter Sales | 20,000 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 12,502,000,000 |
| Last Quarter Net Income | -32,140,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,086,000,000 |
| 60-Month Beta | 2.38 | 0.35 | 0.47 | 0.39 | 0.27 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 1.26 on 02/05/26 |
| Latest Earnings Date | 03/24/21 | 05/05/26 | 05/07/26 | 04/23/26 | 04/30/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | 0.630 on 04/02/26 |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | 04/02/26 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.53 | 16.10 | 17.10 | 9.86 |